HE FANG动物科学学院兽医学· 动物疫苗研发· 新型抗体研发与机制研究个人简介:何放长期从事各类传染病原的疫苗研发，抗体筛选与生产，针对抗体的相应表位，中和机制和治疗诊断的应用都有深入研究，研究对象包括各类禽流感病毒，EV71肠道病毒和各类主要猪病病毒，对禽流感H5N1H7N9等病毒研究有丰富的经验，已研制多种H5N1广谱疫苗，禽流感抗体抗原新型试剂盒，人类手足口症的诊断测试，H7N9的抗体治疗等多项技术创新，研究成果曾在新加坡海峡时报头版报道。已发表有关SCI 文献超过36 篇，其中近半数为第一作者或通讯作者，发表期刊包括Journal of Virology PNAS 等顶级病毒学杂志，申请或授权专利发明9 项。教学与课程:生物医药工程专题动物免疫学研究与成果:PublicationJia Q Ng Q Chin W Meng T Chow VTK Wang CI Kwang J He F*.Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Sci Rep. 2017 Apr 19;7:46402. doi: 10.1038/srep46402.Tan Y He F.* and Kwang J.* (2015) How can we develop universal H5N1 vaccines Immunotherapy 2015 Aug 7: 1-4 (*Corresponding author)P. Rai M. Parrish I. J.J. Tay L. Na S. Ackerman He F. J Kwang V. T.K. Chow and B. P. Engelward. (2015) Streptococcus pneumoniae Secretes Hydrogen Peroxide Leading to DNA Damage and Apoptosis in Lung Cells. PNAS 112(26): E3421-30Kumar SR Prabakaran M K. V. Ashok Raj He F. and J. Kwang (2015) Amino acid Substitutions Improve the Immunogenicity of H7N7HA Protein andProtect Mice against Lethal H7N7 Viral Challenge PLoS One 10(6):e0128940Tan Y Ng QY Jia Q Kwang J and He F. (2015) A novel humanized antibody neutralizes H5N1 via two different mechanisms. . J Virol 89(7):3712-22 He F. Prabakaran M Kumar SR Tan Y Kwang J. (2014) Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice. Antiviral Research. 105:143-151.Prabakaran M. Leyrer S. He F. Auer S. S. R Kumar Kindsmueller K. Mytle N. Schneider J. Lockhart S. Kwang J.. (2014) Progress Toward A Universal H5N1 Vaccine: A Recombinant Modified Vaccina Virus Ankara-expressing Trivalent Hemagglutinin Vaccin. PLoS ONE 17;9(9):e107316.Prabakaran M. S. Rajesh Kumar K. V. Ashok Raj X. Wu He F.. J. Zhou and J. Kwang. (2014). Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes. Antiviral Res 109C:149-159.He F. Prabakaran M Tan Y Indira K Kumar SR Kwang J. (2013) Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus. BMC Microbiol. 2013 Oct 2;13(1):219.He F. S. R. Kumar et al. (2013) Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Research. 100(1):207-14He F and Kwang J. (2013) Monoclonal antibody targeting neutralizing epitope on H5N1 influenza virus of clade 1 and 0 for specific H5 quantification. Influenza Research and Treatment 2013; 2013:360675. doi: 10.1155/2013/360675.He F. T. K. Kiener et al. (2013). Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains. PLoS One 8(1): e55517.Prabakaran M. A. B. Kolpe He F. et al. (2013). "Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge." Vaccine 31(10): 1385-1392.Chen Q. He F. et al. (2012). "GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T B and dendritic cell maturation." J Immunol 189(11): 5223-5229.Kiener TK Jia Q Lim XF He F Meng T et al. (2012) Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J 9: 55.He F and Kwang J. (2011) Universal Recognition and Vaccination of H5N1 Hemagglutinin. Asia Pacific Biotech News 15(11) 19-22Velumani S Ho HT He F Musthaq S Prabakaran M et al. (2011) A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One 6: e20737.Prabakaran M Meng T He F Yunrui T Qiang J et al. (2011) Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice. Clin Vaccine Immunol 18: 1582-1585.He F. Retno D S. Sri M. Goutama M. and Kwang J. (2010). Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus. BMC Microbiol 10 330Prabakaran M He F T Meng S Madhan Y Tan Q Jia and J Kwang. 2010. Neutralizing Epitopes of Influenza Virus Hemagglutinin: Target for the Development of a Universal Vaccine against H5N1 Lineages. J Virol 84: 11822-11830.Chua TH CYH Leung He F CK Chow SK Ma SF Sia IHY Ng SG Fenwick CM James SB Chua ST Chew J Kwang JSM Peiris and TM Ellis. 2010. Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus. Influenza Research and Treatment 2010 Article ID 489213.He F. Madhan S. and Kwang J. (2009). Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Rev Vaccines 8(4) 455-67.He F. Du Q. Ho Y. and Kwang J. (2009). Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP. J Virol Methods 155(1) 25-33.He F. Syed S. M. Hameed A. S. and Kwang J. (2009). Viral ubiquitin ligase WSSV222 is required for efficient white spot syndrome virus (WSSV) replication in shrimp. J Gen Virol 90 (pt6) 1483-90.Ho H. T. Qian H. L. He F. Meng T. Szyporta M. Prabhu N. Prabakaran M. Chan K. P. and Kwang J. (2009). Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies. Clin Vaccine Immunol 16(5) 726-32.Prabhu N. Prabakaran M. He F. Qian H. L. Ho H. T. Jia Q. and Kwang J. (2009) Combination Therapy using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents formation of Escape Mutants. PLoS ONE 4(5) e5672.Prabakaran M. Ho H. T. Prabhu N. Velumani S. Szyporta M. He F. Chan K. P. Chen L. M. Matsuoka Y. Donis R. O. and Kwang J. (2009). Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS ONE 4(2) e4566.Prabhu N M Prabakaran Qian HL He F H Ho J Qiang M Goutama A P Lim BJ Hanson and J Kwang. (2009) Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 hemagglutinin against lethal H5N1 Influenza. Antiviral therapy 14: 911-921.He F. and Kwang J. (2008). Identification and characterization of a new E3 ubiquitin ligase in white spot syndrome virus involved in virus latency. Virol J 5 151.He F. Ho Y. Yu L. and Kwang J. (2008). WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. BMC Microbiol 8 238.Prabakaran M. Velumani S. He F. Karuppannan A. K. Geng G. Y. Yin L. K. and Kwang J. (2008). Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 380(2) 412-20.Liu J. Zhu Y. Chen I. Lau J. He F. Lau A. Wang Z. Karuppannan A. K. and Kwang J. (2007). The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection. J Virol 81(17) 9560-7.He F. Fenner B. J. Godwin A. K. and Kwang J. (2006). White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination. J Virol 80(8) 3884-92.Wang Z. Chua H. K. Gusti A. A. He F. Fenner B. Manopo I. Wang H. and Kwang J. (2005). RING-H2 protein WSSV249 from white spot syndrome virus sequesters a shrimp ubiquitin-conjugating enzyme PvUbc for viral pathogenesis. J Virol 79(14) 8764-72.Patent1. H5 Subtype-specific monoclonal antibodies used for H5 avian influenzaPCT/SG2007/000133 11 May 2007 2. Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereofUS Provisional 60/972059 13 Sep 2007 PCT/SG08/000347 3. Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereofUS Provisional 60/972087 13 Sep 2007 PCT/SG08/000313 4.  Universal vaccine against H5N1 lineagesUS Provisional application 61/329802Filing date: 30 April 2010 5. Monoclonal antibody specific to major neutralizing epitope of influenza H5 hemagglutininPCT (Pending application number)Filing date: 23 August 2010 6. Development of diagnostic monoclonal antibodies for the detection of Enterovirus 71 infection.PCT (Pending application number)Filing date: 20 August 2011 7. Monoclonal antibodies targeting neutralizing epitopes on H5 influenza virus of clade 2.3 8. Monoclonal antibodies targeting neutralizing epitopes on H7 influenza viruses 9. Monovalent H5 vaccine provides broad cross-clade protection against variant H5N1s in mice. 实验室建设:自2013年成立独立的科研团队，有丰富的管理经验和开放的实验室管理模式，重在素质培养和事业发展导向，主张产学研一体的研究生培养方向。